This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The Deal: Dexia, New York Life Seal Asset Management Deal

NEW YORK ( The Deal) -- Franco-Belgian lender Dexia SA and New York Life Investment Management late Tuesday, Sept. 24, sealed a firm deal for Dexia's fund management unit after the two companies entered exclusive talks last week.

New York Life agreed to pay €380 million ($511.9 million) for Dexia Asset Management, the same price as the abortive deal between GCS Capital Partners, of Hong Kong, and Dexia that collapsed in July.

Dexia and New York Life have now signed a share purchase agreement but the deal still needs regulatory approvals.

"The acquisition of Dexia Asset Management will provide our clients with access to the company's highly-rated funds, strong European platform, and established Australian equities business. It builds upon the strong momentum we've achieved in our third-party global asset management business and positions us for further growth in key markets around the world," said New York Life Chairman and CEO John Kim in a statement.

Dexia Asset Management has €74 billion in assets under Management as of July 31, meaning the price equates to about 0.5% of those managed funds. New York Life manages $388 billion. Dexia said the company was one of the final suitors in the original auction for the business.

FinEx Capital Management, of London, said last week it had also submitted an offer for Dexia Asset Management.

Dexia was rescued by the governments of France, Belgium and Luxembourg during the credit crisis of 2008 and then again in 2011 when Europe's sovereign debt problems peaked. In November 2012, it secured another €5.5 billion bailout from the Belgian and French states. Dexia is going through an "orderly resolution" to wind itself down, with notable sales including the disposal of Turkey's DenizBank AS to Russia's Sberbank in August 2012 for about 6.5 billion lira ($3.4 billion).

Dexia and New York Life expect the transaction to close about year-end.

Written by Laura Board

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
AAPL $107.72 0.00%
FB $87.23 0.00%
GOOG $597.79 0.00%
TSLA $238.63 0.00%
YHOO $31.60 0.00%

Markets

Chart of I:DJI
DOW 16,058.35 -469.68 -2.84%
S&P 500 1,913.85 -58.33 -2.96%
NASDAQ 4,636.1050 -140.4030 -2.94%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs